Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Hinge Health (HNGE) EBITDA Margin (2024 - 2025)

Hinge Health's EBITDA Margin history spans 2 years, with the latest figure at 15.97% for Q4 2025.

  • For Q4 2025, EBITDA Margin fell 187.0% year-over-year to 15.97%; the TTM value through Dec 2025 reached 13.3%, changed N/A, while the annual FY2025 figure was 89.88%, 8682.0% down from the prior year.
  • EBITDA Margin for Q4 2025 was 15.97% at Hinge Health, down from 1088.04% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 1088.04% in Q3 2025 and bottomed at 15.97% in Q4 2025.